| Methodology for Using Real-World Data From Electronic Health Records to Assess Chemotherapy Administration in Women With Breast Cancer J Bhimani, K O'Connell, IJ Ergas, M Foley, GB Gallagher, JJ Griggs, ... JCO Clinical Cancer Informatics 8, e2300209, 2024 | 1 | 2024 |
| Patient characteristics associated with intended non-guideline chemotherapy in women with stage I-IIIA breast cancer J Bhimani, K O'Connell, S Persaud, V Blinder, RP Burganowski-Doud, ... Cancer Epidemiology, Biomarkers & Prevention, 2024 | | 2024 |
| Patient characteristics associated with delayed time to adjuvant chemotherapy among women treated for stage I–IIIA breast cancer J Bhimani, K O'Connell, S Persaud, V Blinder, R Burganowski, IJ Ergas, ... International Journal of Cancer, 2024 | | 2024 |
| Trends in chemotherapy use for early-stage breast cancer from 2006 to 2019 J Bhimani, K O’Connell, IJ Ergas, M Foley, GB Gallagher, JJ Griggs, ... Breast Cancer Research 26 (1), 101, 2024 | | 2024 |
| Hypertension and risk of endometrial cancer: a pooled analysis in the Epidemiology of Endometrial Cancer Consortium (E2C2) TS Habeshian, NC Peeri, I De Vivo, LJ Schouten, X Shu, ML Cote, ... Cancer Epidemiology, Biomarkers & Prevention 33 (6), 788-795, 2024 | | 2024 |
| Trends in financial payments from industry to US cancer centers, 2014-2021 N Chakraborty, M Brown, S Persaud, G Gallagher, NU Trivedi, PB Bach, ... JNCI Cancer Spectrum 8 (3), pkae015, 2024 | | 2024 |
| Patient factors associated with chemotherapy modifications: Results from the Optimal Breast Cancer Chemotherapy Dosing (OBCD) study. E Kantor, J Bhimani, GB Gallagher, VS Blinder, RP Burganowski, ... Journal of Clinical Oncology 42 (16_suppl), 520-520, 2024 | | 2024 |
| Trends in pharmaceutical industry payments to US cancer centers, 2014-2021. AP Mitchell, N Chakraborty, M Brown, S Persaud, GB Gallagher, ... Journal of Clinical Oncology 42 (16_suppl), 11065-11065, 2024 | | 2024 |
| Trends in NCCN enforcement of financial conflict of interest policies for guidelines panelists. D Bhamidipati, N Saririan, P Dey, S Persaud, N Chakraborty, S Tabatabai, ... Journal of Clinical Oncology 42 (16_suppl), 11070-11070, 2024 | | 2024 |
| Patient characteristics associated with primary prophylactic granulocyte colony-stimulating factor (G-CSF) use among women treated for early-stage breast cancer. GB Gallagher, K O'Connell, J Bhimani, VS Blinder, RP Burganowski, ... Journal of Clinical Oncology 42 (16_suppl), e12605-e12605, 2024 | | 2024 |
| 1172 PREVALENCE OF PANCREATIC CYSTS AND NEOPLASTIC PROGRESSION DURING IMAGING SURVEILLANCE IN A COHORT OF HIGH-RISK INDIVIDUALS FOR THE DEVELOPMENT OF PANCREATIC CANCER N Zbib, T Nammour, MA Schattner, K Soares, J Flood, S Bayuga-Miller, ... Gastroenterology 166 (5), S-278-S-279, 2024 | | 2024 |
| Industry Payments to Physicians Endorsing Drugs and Devices on a Social Media Platform S Persaud, S Al Hadidi, TS Anderson, G Gallagher, S Chimonas, ... JAMA, 2024 | | 2024 |
| Provider-and facility-level factors in relation to patients’ receipt of chemotherapy, time to chemotherapy initiation, and receipt of guideline regimens: Results from the … E Kantor, K O'Connell, J Bhimani, IJ Ergas, N Heon, GB Gallagher, ... JCO Oncology Practice 19 (11_suppl), 540-540, 2023 | | 2023 |
| The evolving landscape of chemotherapy for the treatment of early-stage breast cancer from 2006-2019: Results of a retrospective cohort study. J Bhimani, K O'Connell, RP Burganowski, IJ Ergas, GB Gallagher, ... Journal of Clinical Oncology 41 (16_suppl), 6600-6600, 2023 | | 2023 |
| Abstract P3-03-16: A methodology for using real-world data from electronic health records to assess chemotherapy administration in women with breast cancer J Bhimani, K O’Connell, RP Burganowski, IJ Ergas, MJ Foley, ... Cancer Research 83 (5_Supplement), P3-03-16-P3-03-16, 2023 | | 2023 |
